José López-Sendón
56 works · 5,708 citations · h-index 20
Top works
- Initial Invasive or Conservative Strategy for Stable Coronary Disease
- Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: Sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria
- Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
- Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
- Antiarrhythmic effect of carvedilol after acute myocardial infarction
- Acute right ventricular infarction secondary to massive pulmonary embolism
- Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
- Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial
- Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event
- Acute myocardial infarction after blunt chest trauma in young people: Need for prompt intervention
- Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events
- Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease
- Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
- Volume loading in patients with ischemic right ventricular dysfunction
- Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score
- Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction
- Vericiguat and NT-proBNP in Patients with Heart Failure with Reduced Ejection Fraction: Analyses from the VICTORIA Trial
- Medical treatment of stable angina: A tailored therapeutic approach
- Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials